百奥泰(688177)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688177 百奥泰

已收盘 04-30 15:00:00

{"stockData":{"symbol":"688177","market":"SH","secType":"STK","nameCN":"百奥泰","latestPrice":33.12,"timestamp":1714460400000,"preClose":33.29,"halted":0,"volume":1865385,"delay":0,"floatShares":413999999,"shares":413999999,"eps":-0.8958,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.17,"latestTime":"04-30 15:00:00","open":32.44,"high":33.59,"low":31.6,"amount":60744000,"amplitude":0.0598,"askPrice":33.12,"askSize":1,"bidPrice":33.09,"bidSize":46,"shortable":0,"etf":0,"ttmEps":-0.8958,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":33.29,"symbolType":"stock_kcb","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":36.62,"lowLimit":29.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":414080000,"pbRate":12.54,"roa":"--","roe":"--","epsLYR":-0.95,"committee":0.190083,"marketValue":13714000000,"floatMarketCap":13714000000,"peRate":-36.972539,"changeRate":-0.0051,"turnoverRate":0.0045,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-06。","afterMarket":{"amount":0,"volume":0,"close":33.12,"buyVolume":0,"sellVolume":0,"time":1714462439505,"indexStatus":"已收盘 04-30 15:30:00","preClose":33.29}},"requestUrl":"/m/hq/s/688177","defaultTab":"news","newsList":[{"id":"2431280034","title":"百奥泰大跌5.05% 近半年7家券商买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2431280034","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2431280034?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:35","pubTimestamp":1714440944,"startTime":"0","endTime":"0","summary":"04月30日，百奥泰股价大幅下跌，截至09点35分，百奥泰下跌5.05%，报31.61元/股，成交1024万元，换手率0.08%，振幅4.45%。此外，数据统计显示，近半年内7家券商给予买入建议。资金动向截止发稿，百奥泰获得主力净流出121万元，其中超大单流出4万元，大单流出115万元。北向资金方面，百奥泰04月29日获得北向资金减持10.77万股，截至04月29日，北向资金当前共持有百奥泰253.36万股，市值8008万元，持股占流通股比为0.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300939087a578658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300939087a578658&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431381224","title":"图解百奥泰一季报：第一季度单季净利润同比增16.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431381224","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431381224?lang=zh_cn&edition=full","pubTime":"2024-04-30 01:59","pubTimestamp":1714413592,"startTime":"0","endTime":"0","summary":"证券之星消息，百奥泰2024年一季报显示，公司主营收入1.62亿元，同比上升4.3%；归母净利润-1.19亿元，同比上升16.57%；扣非净利润-1.23亿元，同比上升27.77%；负债率51.59%，财务费用386.19万元，毛利率69.91%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000002693.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431837750","title":"百奥泰(688177.SH)发布一季度业绩，净亏损1.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431837750","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431837750?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:27","pubTimestamp":1714390031,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥泰(688177.SH)发布2024年一季度报告，报告期内公司实现营业收入1.62亿元，同比增加4.3%;归属于上市公司股东的净亏损1.19亿元;归属于上市公司股东的扣除非经常性损益的净亏损1.23亿元;基本每股亏损0.29元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114743.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430241999","title":"百奥泰：托珠单抗注射液获欧洲药品管理局人用药品委员会积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=2430241999","media":"国际金融报","top":-1,"share":"https://www.laohu8.com/m/news/2430241999?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:13","pubTimestamp":1714119204,"startTime":"0","endTime":"0","summary":"百奥泰公告，TOFIDENCE(托珠单抗注射液)获欧洲药品管理局人用药品委员会积极意见。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261613577a5607ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404261613577a5607ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430298482","title":"北向资金4月25日净买入百奥泰3.08万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430298482","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430298482?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:30","pubTimestamp":1714095037,"startTime":"0","endTime":"0","summary":"4月25日, 北向资金增持百奥泰3.08万股，连续3日增持。截止当日收盘，沪股通共持有百奥泰250.22万股，占流通股0.60%。沪股通增持金额前五个股分别为招商银行、中国平安、紫金矿业、中控技术、中信证券。百奥泰近5个交易日上涨8.45%，沪股通累计增持33.22万股；近20个交易日下跌14.82%，沪股通累计增持85.66万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260935108b54f46d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260935108b54f46d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429597969","title":"北向资金4月19日净买入百奥泰3.51万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429597969","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429597969?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:30","pubTimestamp":1713749433,"startTime":"0","endTime":"0","summary":"4月19日, 北向资金增持百奥泰3.51万股，连续3日增持。截止当日收盘，沪股通共持有百奥泰220.51万股，占流通股0.53%。沪股通增持金额前五个股分别为万华化学、中信证券、珀莱雅、华阳股份、平煤股份。百奥泰近5个交易日下跌11.86%，沪股通累计增持36.89万股；近20个交易日下跌27.74%，沪股通累计增持67.98万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422093503879ecbce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422093503879ecbce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428363055","title":"百奥泰大幅上涨 近半年7家券商买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2428363055","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2428363055?lang=zh_cn&edition=full","pubTime":"2024-04-17 10:01","pubTimestamp":1713319262,"startTime":"0","endTime":"0","summary":"04月17日，百奥泰股价大幅上涨，截至10点01分，百奥泰上涨5.00%，报29.84元/股，成交1995万元，换手率0.16%，振幅4.86%。此外，数据统计显示，近半年内7家券商给予买入建议。资金动向截止发稿，百奥泰获得主力净流出138万元，其中超大单流出290万元，大单流入152万元。北向资金方面，百奥泰04月16日获得北向资金减持3.76万股，截至04月16日，北向资金当前共持有百奥泰182.92万股，市值5458万元，持股占流通股比为0.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417140308792120a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417140308792120a6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427855934","title":"手机厂生产汽车？如何理解“跨次元”制造？","url":"https://stock-news.laohu8.com/highlight/detail?id=2427855934","media":"银华基金","top":-1,"share":"https://www.laohu8.com/m/news/2427855934?lang=zh_cn&edition=full","pubTime":"2024-04-16 07:44","pubTimestamp":1713224651,"startTime":"0","endTime":"0","summary":"一家以智能手机和智能家居产品闻名的科技企业，其进军汽车行业的消息一经发布，便引起了市场的广泛关注和热议。产业融合下，“跨次元”的企业生产出的产品具有创新性、多样性和高度集成的优势。通过高新技术的深度整合，“跨次元”企业能够快速响应市场变化，满足消费者对于个性化和智能化的需求。六、以上基金由银华基金依照有关法律法规及约定申请募集，并经中国证券监督管理委员会许可注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041607421687e808af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041607421687e808af&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427069750","title":"百奥泰(688177)：生物类似药高速增长 创新药管线顺利推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2427069750","media":"太平洋证券股份...","top":-1,"share":"https://www.laohu8.com/m/news/2427069750?lang=zh_cn&edition=full","pubTime":"2024-04-15 21:32","pubTimestamp":1713187932,"startTime":"0","endTime":"0","summary":"BAT1806 是第一款由中国本土药企自主研发、生产且获得美国 FDA批准上市的单克隆抗体药物，也是美国FDA 批准的第一款托珠单抗生物类似药。我们预计在2024 年公司将针对以上三个品种密集对外授权，进一步拓宽公司生物类似药板块的海外市场。创新药管线顺利推进。盈利预测及投资评级：公司获批新品有望继续放量，多款生物类似药出海贡献收入弹性，未来收入将快速增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152132228b263fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404152132228b263fdd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427207845","title":"百奥泰：BAT2206计划于今年上半年递交美国FDA和CDE上市申请，BAT8006 II期临床试验申请已获FDA许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2427207845","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427207845?lang=zh_cn&edition=full","pubTime":"2024-04-15 18:17","pubTimestamp":1713176257,"startTime":"0","endTime":"0","summary":"BAT1706 和BAT1806 目前尚在 EMA 的评审的过程中，公司会积极跟进并推动相关进程。BAT2206计划于今年上半年递交美国 FDA 和 CDE 上市申请；BAT8006 目前处于 II 期临床试验阶段，BAT8006 的 II 期临床试验申请已于近期获得美国食品药品监督管理局的许可，公司计划于 6月初在 2024 年美国临床肿瘤学会年会上展示 BAT8006的临床数据。公司计划于今年下半年递交 BAT2506 美国 FDA 上市申请，于 2025 年递交 BAT2506和 BAT2306 的 CDE 上市申请。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151820268b25999f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151820268b25999f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427762026","title":"4月15日百奥泰跌5.31%，富国医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427762026","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2427762026?lang=zh_cn&edition=full","pubTime":"2024-04-15 16:41","pubTimestamp":1713170472,"startTime":"0","endTime":"0","summary":"证券之星消息，4月15日百奥泰跌5.31%，收盘报30.5元，换手率0.94%，成交量3.9万手，成交额1.19亿元。重仓百奥泰的前十大公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级4家。根据2023基金年报公募基金重仓股数据，重仓该股的公募基金共20家，其中持有数量最多的公募基金为富国医疗保健行业混合A。富国医疗保健行业混合A目前规模为10.97亿元，最新净值2.886，较上一交易日上涨0.52%，近一年下跌17.68%。该公募基金现任基金经理为孙笑悦。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415164331877eafab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415164331877eafab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427016420","title":"百奥泰大跌创2月新低 近半年6家券商买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2427016420","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2427016420?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:56","pubTimestamp":1713146214,"startTime":"0","endTime":"0","summary":"04月15日，百奥泰股价大幅下跌，截至09点56分，百奥泰下跌5.12%，报30.56元/股，创近2月新低，成交2172万元，换手率0.17%。此外，数据统计显示，近半年内6家券商给予买入建议。资金动向截止发稿，百奥泰获得主力净流出501万元，其中超大单流出825万元，大单流入325万元。北向资金方面，百奥泰04月12日获得北向资金增持10.47万股，连续5日增持，截至04月12日，北向资金当前共持有百奥泰183.62万股，市值5611万元，持股占流通股比为0.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151107307a52b519&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404151107307a52b519&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427915092","title":"北向资金4月12日净买入百奥泰10.47万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2427915092","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427915092?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:30","pubTimestamp":1713144632,"startTime":"0","endTime":"0","summary":"4月12日, 北向资金增持百奥泰10.47万股，连续5日增持。截止当日收盘，沪股通共持有百奥泰183.62万股，占流通股0.44%。沪股通增持金额前五个股分别为兆易创新、海光信息、金山办公、江西铜业、中贝通信。百奥泰近5个交易日下跌8.05%，沪股通累计增持37.26万股；近20个交易日下跌12.14%，沪股通累计增持35.82万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150936198b23adf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404150936198b23adf1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426474832","title":"北向资金4月10日净买入百奥泰3.30万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2426474832","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426474832?lang=zh_cn&edition=full","pubTime":"2024-04-11 09:30","pubTimestamp":1712799037,"startTime":"0","endTime":"0","summary":"4月10日, 北向资金增持百奥泰3.30万股，连续3日增持。截止当日收盘，沪股通共持有百奥泰172.97万股，占流通股0.41%。沪股通增持金额前五个股分别为工业富联、济川药业、中国平安、兴业银行、福莱特。百奥泰近5个交易日下跌6.77%，沪股通累计增持10.99万股；近20个交易日下跌8.28%，沪股通累计减持103.44万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110935098b0d62bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110935098b0d62bf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426613047","title":"百奥泰04月09日遭主力抛售892万元 环比增加112.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426613047","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426613047?lang=zh_cn&edition=full","pubTime":"2024-04-09 15:18","pubTimestamp":1712647138,"startTime":"0","endTime":"0","summary":"04月09日, 百奥泰股价涨1.06%，报收34.39元，成交金额4986万元，换手率0.36%，振幅4.03%，量比1.07。百奥泰今日主力资金净流出892万元，连续4日净流出，上一交易日主力净流出419万元，今日环比增加112.89%。该股近5个交易日下跌3.94%，主力资金累计净流出2353万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出849万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409153135875889d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409153135875889d1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426974374","title":"百奥泰(688177)：生物类似药进入收获期 ADC管线持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2426974374","media":"华鑫证券","top":-1,"share":"https://www.laohu8.com/m/news/2426974374?lang=zh_cn&edition=full","pubTime":"2024-04-09 07:54","pubTimestamp":1712620449,"startTime":"0","endTime":"0","summary":"百奥泰股份发布公告： 2023 年度，公司实现营业收入 7.05亿元，同比增长 54.86%。托珠单抗于 2023 年 1 月在国内获批上市，三个适应症，目前已覆盖100 多家各省级商业公司和 300 多家医院终端，贡献了2023 年的部分新增量。稳步推进新药研发公司2023 年研发投入7.69 亿元，同比增长24.70%，公司生物类似物海外上市有望逐步支撑起研发的持续投入。BAT8006 已有同靶点的ADC 药物获得美国FDA 许可上市，该靶点在多种实体肿瘤如卵巢癌、肺癌、子宫内膜癌和乳腺癌中过表达。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040907541087564b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040907541087564b3b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425956663","title":"百奥泰04月08日主力资金流出419万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2425956663","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425956663?lang=zh_cn&edition=full","pubTime":"2024-04-08 15:18","pubTimestamp":1712560693,"startTime":"0","endTime":"0","summary":"04月08日, 百奥泰股价跌2.85%，报收34.03元，成交金额6123万元，换手率0.42%，振幅7.17%，量比1.48。百奥泰今日主力资金净流出419万元，连续3日净流出，上一交易日主力净流出1004万元，今日环比减少58.27%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为60.87%，平均跌幅为2.18%。该股近5个交易日下跌8.03%，主力资金累计净流出2263万元；近20日主力资金累计净流入139万元，其中净流入天数为8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408152930875361fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408152930875361fc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424896311","title":"百奥泰：产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2424896311","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2424896311?lang=zh_cn&edition=full","pubTime":"2024-04-03 16:44","pubTimestamp":1712133895,"startTime":"0","endTime":"0","summary":"每经AI快讯，百奥泰 4月3日晚间发布公告称，百奥泰生物制药股份有限公司于近日收到国家药品监督管理局核准签发的关于托珠单抗注射液的《药品注册证书》。产品名称为“托珠单抗注射液”。2023年1至12月份，百奥泰的营业收入构成为：医药制造占比100.0%。百奥泰的总经理、董事长均是LI SHENGFENG(李胜峰)，男，65岁，学历背景为博士。截至发稿，百奥泰市值为145亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040317021587d9f242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040317021587d9f242&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424893344","title":"百奥泰：托珠单抗注射液（施瑞立）获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2424893344","media":"21世纪经济报道","top":-1,"share":"https://www.laohu8.com/m/news/2424893344?lang=zh_cn&edition=full","pubTime":"2024-04-03 16:31","pubTimestamp":1712133060,"startTime":"0","endTime":"0","summary":"南方财经4月3日电，百奥泰公告，托珠单抗注射液（施瑞立）获得药品注册证书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040316313687d9c85f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040316313687d9c85f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424786177","title":"百奥泰04月03日遭主力抛售1004万元 环比增加1908.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424786177","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424786177?lang=zh_cn&edition=full","pubTime":"2024-04-03 15:19","pubTimestamp":1712128783,"startTime":"0","endTime":"0","summary":"04月03日, 百奥泰股价跌0.14%，报收35.03元，成交金额5279万元，换手率0.36%，振幅3.42%，量比1.36。百奥泰今日主力资金净流出1004万元，上一交易日主力净流出50万元，今日环比增加1908.00%。该股近5个交易日下跌4.03%，主力资金累计净流出1911万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入1039万元，其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031539238aec5d15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031539238aec5d15&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-02-21","address":"广东省广州市黄埔区高新技术产业开发区科学城开源大道11号A6栋第五层","stockEarnings":[{"period":"1week","weight":0.1159},{"period":"1month","weight":-0.0749},{"period":"3month","weight":0.0289},{"period":"6month","weight":-0.1226},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.1969}],"companyName":"百奥泰生物制药股份有限公司","boardCode":"AI0027","perCapita":"56322股","boardName":"医药制造业","registeredCapital":"41408万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":"　　百奥泰生物制药股份有限公司的主营业务是药物的研发、生产和销售。公司的主要产品是创新药和生物类似药，用于治疗肿瘤、自身免疫性疾病、心血管疾病以及其它危及人类生命或健康的重大疾病。","serverTime":1714650156409,"listedPrice":32.76,"stockholders":"7352人(较上一季度减少0.97%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥泰(688177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥泰(688177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥泰,688177,百奥泰股票,百奥泰股票老虎,百奥泰股票老虎国际,百奥泰行情,百奥泰股票行情,百奥泰股价,百奥泰股市,百奥泰股票价格,百奥泰股票交易,百奥泰股票购买,百奥泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥泰(688177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥泰(688177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}